Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16401-14-2

Post Buying Request

16401-14-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16401-14-2 Usage

Uses

5-Isoxazolecarbaldehyde is the derivative of 5-Isoxazolecarboxylic Acid, which is used as a reagent in the synthesis of N-(benzo[1,2,3]triazol-1-yl)-N-((benzyl)acetamido)phenyl carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors. 5-Isoxazolecarboxylic Acid is also used as a reagent in the synthesis of TC-6683, a α4β2 nicotinic acetylcholine receptor agonist for treatment of cognitive disorders.

Check Digit Verification of cas no

The CAS Registry Mumber 16401-14-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,4,0 and 1 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 16401-14:
(7*1)+(6*6)+(5*4)+(4*0)+(3*1)+(2*1)+(1*4)=72
72 % 10 = 2
So 16401-14-2 is a valid CAS Registry Number.
InChI:InChI=1/C4H3NO2/c6-3-4-1-2-5-7-4/h1-3H

16401-14-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,2-oxazole-5-carbaldehyde

1.2 Other means of identification

Product number -
Other names 5-Formylisoxazol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16401-14-2 SDS

16401-14-2Relevant articles and documents

-

Adembri,G. et al.

, p. 4697 - 4707 (1967)

-

INTEGRASE INHIBITORS 3

-

Page/Page column 61, (2008/06/13)

The present invention provides a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable derivative, salt or prodrug thereof. Compounds of formula (I) are also provided.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16401-14-2